Quick answers
- What is Eliquis?
- Eliquis is a brand name of Apixaban, a prescription medicine. The FDA NDC Directory lists 13 Eliquis products in 3 strengths and forms.
- Who makes Eliquis?
- Bristol Myers Squibb holds the FDA application for Eliquis (NDA202155, approved December 28, 2012). 5 other companies (repackagers or distributors) also list Eliquis products.
- Is there a generic or store brand of Eliquis?
- Yes. The FDA NDC Directory lists 4 other products with the same active ingredients, strength and form as a Eliquis product, 4 of them generic. Ask your pharmacist whether one is right for you.
- What do pharmacies pay for Eliquis?
- CMS lists a National Average Drug Acquisition Cost (NADAC) for 2 Eliquis strengths and forms (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
- Has Eliquis been recalled?
- FDA enforcement reports list 1 recall of Eliquis products; the newest started June 5, 2017. A recall usually concerns specific lots, not every product.
What Eliquis is
Each Eliquis product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Apixaban · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| apixaban 0.5 mg tablet, for suspension (oral) | Eliquis | None listed | — |
| apixaban 2.5 mg tablet, film coated (oral) | Eliquis | 2 products, 2 companies | DailyMed |
| apixaban 5 mg tablet, film coated (oral) | Eliquis | 2 products, 2 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Apixaban →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA202155 | Bristol Myers Squibb | December 28, 2012 | 13 |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| apixaban 2.5 mg tablet, film coated | Brand: Eliquis | $5.51 per tablet |
| apixaban 5 mg tablet, film coated | Brand: Eliquis | $5.52 per tablet |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list Eliquis
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Eliquis products.
- A-S Medication Solutions4 products
- E.R. Squibb & Sons, L.L.C.3 products
- Cardinal Health 107, LLC2 products
- Aphena Pharma Solutions - Tennessee, LLC2 products
- Remedyrepack Inc.1 product
- Proficient Rx LP1 product
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
June 5, 2017 · Class I · Terminated · D-0959-2017
Labeling: Label Mix-up: One bottle of Eliquis 5 mg tablet was found to contain lower-strength Eliquis 2.5 mg tablets only instead of the labeled 5 mg tablets.
EliquisTablets 5mg, 60 count bottle, Rx Only, Marketed by: Bristol-Meyers Squibb Company Princeton, NJ 08543 USA and Pfizer Inc. New York, NY 10017 USA, NDC 0003-0894-21 — Bristol-myers Squibb Company
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.